Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Isopropylamine → 5-Isopropylamino-4-hydroxypentanoic acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Isopropylamine | HCID 6363 | — |
| 반응물 | Homoveratrylamine | HCID 8421 | — |
| 반응물 | Chlorolactic acid | HCID 92899 | — |
| 반응물 | 4-Hydroxy-5-chloropentanoic acid | HCID 20240654 | — |
| 생성물 | 5-Isopropylamino-4-hydroxypentanoic acid | HCID 20240650 | — |
반응 단계
The procedure is repeated in all essential details, except 4-hydroxy-5-chloropentanoic acid is substituted for β-chlorolactic acid and isopropylamine is substituted for 3,4-dimethoxyphenethylamine to produce the intermediate 5-isopropylamino-4-hydroxypentanoic acid. The hydroxy and amino groups are protected as described in Example I. The resulting acid is reacted with 1-naphthol instead of phenol and the protecting groups are removed as in Example I. The resulting compound should be a short acting β-blocker.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US04604481 |
| 출처 데이터셋 | uspto-grants-1986_08 |
| ORD ID | ord-14d303843c2a4c13a782419fb3c78137 |
| 출처 메모 | uspto-grants-1986_08 |